Camber Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $21.6M | Buy |
|
|||||
|
2021
Q4 | $50.7M | Hold |
|
|||||
|
2021
Q3 | $67.3M | Buy |
|
|||||
|
2021
Q2 | $60.1M | Buy |
|
|||||
|
2021
Q1 | $40M | Sell |
|
|||||
|
2020
Q4 | $42.5M | Hold |
|
|||||
|
2020
Q3 | $41.5M | Sell |
|
|||||
|
2020
Q2 | $69.5M | Hold |
|
|||||
|
2020
Q1 | $53.5M | Sell |
|
|||||
|
2019
Q4 | $80.9M | Buy |
|
|||||
|
2019
Q3 | $54.6M | Buy |
|
|||||
|
2019
Q2 | $89M | Buy |
|
|||||
|
2019
Q1 | $67.2M | Hold |
|
|||||
|
2018
Q4 | $65.7M | Buy |
|
|||||
|
2018
Q3 | $91.4M | Sell |
|
|||||
|
2018
Q2 | $97.7M | Buy |
|
|||||
|
2018
Q1 | $159M | Sell |
|
|||||
|
2017
Q4 | $200M | Sell |
|
|||||
|
2017
Q3 | $125M | Sell |
|
|||||
|
2017
Q2 | $105M | Sell |
|
|||||
|
2017
Q1 | $127M | Sell |
|
|||||
|
2016
Q4 | $73.6M | Buy |
|
|||||
|
2016
Q3 | $55M | Sell |
|
|||||
|
2016
Q2 | $60.5M | Sell |
|
|||||
|
2016
Q1 | $61.9M | Buy |
|
|||||
|
2015
Q4 | $59M | Buy |
|
|||||
|
2015
Q3 | $24.7M | Buy |
|
|||||
|
2015
Q2 | $18.8M | Buy |
|